Vascular access occlusion results in significant morbidity in hemodial
ysis patients. Age, diabetes, and synthetic grafts (polytetrafluoroeth
ylene [PTFE]) have been associated with vascular access occlusion in u
nivariate analysis. However, the independent risk associated with each
of these factors has not been assessed adjusting for confounding amon
g the factors or by other variables, such as blood pressure (BP) or he
matocrit. The influence of serum lipoprotein(a) [Lp(a)] and fibronecti
n on vascular access occlusion has not been widely studied despite the
ir theoretical or demonstrated importance in vascular bypass occlusion
. In a cohort study of 124 hemodialysis patients monitored for up to 1
4 months, we reported that Lp(a) values in the upper tertile (greater
than or equal to 57 mg/dL) were associated with vascular access occlus
ion risk in white and Hispanic patients, but not in black patients. We
now report an expanded analysis of this data set to determine the ind
ependent correlates of vascular access occlusion. Variables tested inc
luded age, race, gender, diabetes, access type (PTFE v endogenous), tr
eatment time, systolic BP, hematocrit, heparin and erythropoietin dosa
ge, and serum levels of Lp(a) and fibronectin. In univariate analysis,
access occlusion was associated with age, diabetes, PTFE, Lp(a) great
er than or equal to 57 mg/dL, serum fibronectin, and reduced BP. The i
ndependent correlates of first access occlusion were determined with t
he Cox proportional hazards model. Since the overall model included a
significant race x Lp(a) interaction term, we stratified by race. In b
lack patients, risk correlated directly with PTFE (P < 0.01) and inver
sely with systolic BP (P < 0.001), whereas for white and Hispanic pati
ents, age (P = 0.04) and Lp(a) greater than or equal to 57 mg/dL (P =
0.05) were associated with increased risk. In summary, vascular access
occlusion was found to be associated with a number of factors. Import
ant independent correlates were PTFE and lower BP in black patients, a
nd age and serum Lp(a) greater than or equal to 57 mg/dL in white and
Hispanic patients. Diabetes mellitus and increased serum fibronectin m
ay contribute additional risk. (C) 1994 by the National Kidney Foundat
ion, Inc.